Brown adipose tissue alleviates podocyte apoptosis through NRG4 in a male mouse model of diabetic kidney disease
- 27 February 2025
- journal article
- research article
- Published by Springer Nature in Diabetologia
- Vol. 68 (5) , 1057-1075
Abstract
Aims/hypothesis Brown adipose tissue (BAT) consumes excess energy through heat production by uncoupling protein 1 (UCP1) to regulate the metabolic profile, but the UCP1-independent mechanisms of BAT, such as in endocrine function, are largely unknown. Our previous study showed that BAT-derived neuregulin 4 (NRG4) displays anti-atherosclerotic properties. Thus, we hypothesised that BAT could regulate diabetic nephropathy, a diabetic microvascular complication, via NRG4. Methods To investigate the influence of NRG4 from BAT on podocyte apoptosis, both loss- and gain-of-function approaches were used in in vivo experiments. Diabetic nephropathy models were created using BAT-specific Nrg4-knockout (BKO) mice, global Nrg4-knockout (KO) mice and wild-type (WT) mice. In in vitro studies, podocytes (MPC5) were exposed to glucose and recombinant NRG4 (rNrg4). Additionally, brown adipocytes were co-cultured with MPC5 podocytes using a transwell system. The expression levels of proteins associated with podocyte apoptosis and signalling pathways were measured. Results BAT-specific NRG4 deficiency aggravated podocyte apoptosis (increased by 47.46%) and increased the urinary albumin/creatinine ratio (increased by 41.71%), decreased nephrin expression and increased desmin expression. As expected, these changes were reversed by NRG4 replenishment using adeno-associated virus–NRG4 interscapular BAT injection and BAT transplantation assays in KO mice. Additionally, co-culture experiments demonstrated that brown adipocytes from WT mice could alleviate high-glucose-induced podocyte apoptosis. In in vitro experiments, recombinant NRG4 inhibited high-glucose-induced podocyte apoptosis. Mechanistically, the Akt–glycogen synthase kinase 3 β (GSK-3β) pathway is crucial for the protection that BAT-derived NRG4 provides to podocytes in diabetic nephropathy. Conclusions/interpretation Our data show that BAT had a protective effect on podocyte apoptosis in diabetic nephropathy through BAT-derived NRG4, and the Akt–GSK‑3β signalling pathway may mediate the inhibition of BAT-derived NRG4 on podocyte apoptosis in diabetic nephropathy. Graphical AbstractKeywords
Funding Information
- Research Project of Hubei Administration of Traditional Chinese Medicine (No. ZY2023F060)
- Wuhan Medical Science Research Project (No. WX23A56)
- National Natural Science Foundation of China (No. 82170857)
- National Natural Science Foundation of China (81870573)
- Natural Science Foundation of Project of Hubei Province (No. 2022CFC022)
This publication has 45 references indexed in Scilit:
- NRG4: An Endocrine Link between Brown Adipose Tissue and LiverCell Metabolism, 2015
- The brown fat–enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesisNature Medicine, 2014
- AKT2 is essential to maintain podocyte viability and function during chronic kidney diseaseNature Medicine, 2013
- Role of Bad in Podocyte Apoptosis Induced by Puromycin AminonucleosideTransplantation Proceedings, 2013
- Emerging role of neuregulin as a modulator of muscle metabolismAmerican Journal of Physiology-Endocrinology and Metabolism, 2010
- Inhibition of PI3-kinase signaling by glucocorticoids results in increased branched-chain amino acid degradation in renal epithelial cellsAmerican Journal of Physiology-Cell Physiology, 2007
- Insulin-like growth factors inhibit podocyte apoptosis through the PI3 kinase pathwayKidney International, 2005
- Diabetic Nephropathy: Diagnosis, Prevention, and TreatmentDiabetes Care, 2005
- Phosphorylation and Inactivation of BAD by Mitochondria-Anchored Protein Kinase AMolecular Cell, 1999
- Pathogenesis, prevention, and treatment of diabetic nephropathyThe Lancet, 1998